CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 200 enrolled
Drug / intervention
Procalcitonin +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02899065
NCT02899065N/ACompleted
CompareCT.gov

Evaluation of the Roche Cobas Liat Flu/RSV Assay for Management of Influenza in the Emergency Department

University of California, Davis·interventional·Posted Sep 14, 2016·Updated Oct 17, 2023

In Brief

A clinical study evaluating Procalcitonin and Pharmacist-Led Education for Influenza, Human. Completed, enrolled 200 participants across 1 site.

Detailed Summary

This will be a prospective, patient-oriented, pilot randomized clinical trial to evaluate (in aggregate) both the use of the Roche Cobas Liat Flu/RSV Assay and the use of pharmacist-led education for providers in the interpretation of these test results.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza, Human
CountriesUnited States
CollaboratorsRoche Pharma AG

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 14, 2016
Enrollment StartMar 6, 2018
Primary CompletionApr 15, 2022
Study CompletionMay 20, 2022
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 9.8 years ago

Interventions

Procalcitoninother

Procalcitonin is a blood test used to differentiate between viral and bacterial infections. This test is expected to aid in determining the best course of treatment for patients enrolled into this arm.

Pharmacist-Led Educationother

Pharmacists will interpret the results of the Roche Cobas Liat Flu/RSV assay and procalcitonin test (if available) and provide the treating physician with recommendations for antibiotic therapy based on these results.